Labfront
PrivateLast Round
Accelerator
Aug 9, 2022
Est. Valuation
$1.67M
Total Funding Raised
$700,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Labfront operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was an Accelerator round in August 2022.
Labfront is a healthcare technology company that provides a code-free digital biomarker collection and analytics platform for academic researchers.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Health IoT, Data Integration, Data Visualization
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Labfront Comparables
Compare Labfront with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fitabase | 91% | |
| PhysioQ | 87% | |
| VivoSense | 78% |
For institutional investors. Book with your work email.
Labfront Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 9, 2022 | ||||
| Accelerator | Jul 12, 2022 | ||||
| Pre Seed | Jun 28, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Labfront Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 500 Global | Pre Seed, Accelerator |
| Taiwan Tech Arena | Accelerator |
| MassChallenge Israel | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 80% MoM.
- Mar 9, 2026
Collaborating with Zana Technologies GmbH on digital health research.
For institutional investors. Book with your work email.
Labfront Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Labfront's valuation, stock price, and market status.
Is Labfront a public or private company?
Labfront is a private company.
What is the current stock price of Labfront?
Labfront is a private company, so its shares have no public market price. Caplight tracks Labfront's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Labfront worth (valuation)?
Labfront's valuation is estimated at $1.7M based on funding round data.
Can I buy Labfront stock?
Labfront shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Labfront's last funding round?
Labfront's most recent funding round was Accelerator on August 9, 2022.
Who are the main investors in Labfront?
Key investors in Labfront include 500 Global, Taiwan Tech Arena, MassChallenge Israel.
Will Labfront IPO soon?
No public IPO plans have been announced for Labfront.
How can I track Labfront secondary market activity?
Caplight tracks bids, offers, and trades in Labfront's shares on secondary markets.